Icon (ICLR) Retained Earnings (2009 - 2026)
Icon's (ICLR) quarterly Retained Earnings came in at $2.3 billion in Q2 2026, down 10.24% year-over-year from $2.6 billion in Q2 2025, and up 3.26% quarter-over-quarter from $2.2 billion in Q1 2026.
Analysis
Icon (ICLR) Retained Earnings (2009 - 2026) Analysis & Trends
Icon (ICLR) has reported Retained Earnings for 18 consecutive years, with $2.3 billion the latest figure, recorded in Q2 2026.
- On a quarterly basis, Retained Earnings fell 10.24% year-over-year to $2.3 billion in Q2 2026; TTM through Jun 2026 was $2.3 billion, a 10.24% decrease from a year earlier, with the FY2025 full-year figure at $2.1 billion, down 32.9% from the prior year.
- Retained Earnings was $2.3 billion for Q2 2026 at Icon, up from $2.2 billion in the prior quarter.
- Over five years, Retained Earnings peaked at $3.2 billion in Q4 2024 and troughed at $1.4 billion in Q1 2022.
- A 5-year average of $2.3 billion and a median of $2.3 billion in 2026 frame the typical range for Retained Earnings.
- Across the five-year window, Retained Earnings surged 35.71% in 2023 and sank 32.9% in 2025, its largest moves.
- Over 5 years, Retained Earnings stood at $2.2 billion in 2022, then grew by 8.33% to $2.4 billion in 2023, then soared by 31.53% to $3.2 billion in 2024, then slumped by 32.9% to $2.1 billion in 2025, then grew by 8.36% to $2.3 billion in 2026.
- The last three Retained Earnings figures came in at $2.3 billion (Q2 2026), $2.2 billion (Q1 2026), and $2.1 billion (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 7.96 Bn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | -511.37 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 2.30 Bn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 1.37 Bn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 2.14 Bn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | 1.71 Bn |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | 6.70 Bn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | -81.50 Mn |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | -106.74 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | -357.34 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.30 Bn |
| Mar 31, 2026 | 2.23 Bn |
| Dec 31, 2025 | 2.12 Bn |
| Sep 30, 2025 | 2.31 Bn |
| Jun 30, 2025 | 2.56 Bn |
| Mar 31, 2025 | 2.63 Bn |
| Dec 31, 2024 | 3.16 Bn |
| Sep 30, 2024 | 2.87 Bn |
| Jun 30, 2024 | 2.77 Bn |
| Mar 31, 2024 | 2.62 Bn |
| Dec 31, 2023 | 2.40 Bn |
| Sep 30, 2023 | 2.22 Bn |
| Jun 30, 2023 | 2.05 Bn |
| Mar 31, 2023 | 1.94 Bn |
| Dec 31, 2022 | 2.22 Bn |
| Sep 30, 2022 | 1.70 Bn |
| Jun 30, 2022 | 1.54 Bn |
| Mar 31, 2022 | 1.43 Bn |
| Dec 31, 2021 | 1.73 Bn |
| Sep 30, 2021 | 1.34 Bn |